|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/28 | |||
| A61K 38/10 | |||
| A61P 1/00 | |||
| A61P 29/02 | |||
| A61P 13/10 |
| (11) | Patento numeris | 3302440 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16729739.9 |
| Europos patento paraiškos padavimo data | 2016-06-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-04-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-01-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/035886 |
| Data | 2016-06-03 |
| (87) | Numeris | WO 2016/197042 |
| Data | 2016-12-08 |
| (30) | Numeris | Data | Šalis |
| 201562171462 P | 2015-06-05 | US | |
| 201662339462 P | 2016-05-20 | US |
| (72) |
HASHASH, Ahmad, US
|
| (73) |
Ironwood Pharmaceuticals, Inc.,
100 Summer Street, Suite 2300, Boston, MA 02110,
US
|
| (54) | MODIFIED OR TARGETED RELEASE FORMULATIONS OF LINACLOTIDE |
| MODIFIED OR TARGETED RELEASE FORMULATIONS OF LINACLOTIDE |